The interferon-inducible gene IFI16 secretome of endothelial cells drives the early steps of the inflammatory response / Baggetta R; De Andrea M; Gariano G R; Mondini M; Rittà M; Caposio P; Cappello P; Giovarelli M; Gariglio M; Landolfo S.
Introduction
The IFI16 gene, a member of the HIN200 family, encodes a nuclear phosphoprotein 1-3 believed to belong to the DNA repair system and is triggered by various stimuli including IFN (IFN-α/β andγ), oxidative stress, cell density and some proinflammatory cytokines, such as TNF-α 4, 5. In addition to partially conserved repeat motifs of 200 amino acids, designated A, B and C, the IFI16 protein contains a DAPIN/PYRIN domain within its N-terminus 6, 7. This domain was identified as a putative protein-protein interaction domain at the N-terminus of several other proteins believed to function in inflammatory signalling pathways. Consistent with these observations, prominent in vivo IFI16 expression has been demonstrated in lymphocytes, monocytes, stratified squamous epithelia and endothelial cells (EC) isolated from both blood and lymph vessels 8, 9, suggesting a role for IFI16 in the modulation of inflammation and the immune response. We have previously shown that IFI16 overexpression in EC triggered at the transcriptional level the expression of both adhesion molecules (such as ICAM-1) and chemokines (such as CCL2 and CCL20) 9. The treatment of cells with short hairpin RNA, targeting IFI16 significantly inhibited ICAM-1 induction by IFN-γ demonstrating that IFI16 is required for proinflammatory gene stimulation by this cytokine. Moreover, functional analysis of the ICAM-1 promoter demonstrated that NF-κB, one of the main transcription factors activated during inflammation, is the main mediator of IFI16-driven ICAM-1 induction by IFN-γ. Additionally, anti-IFI16 autoAb are present at much greater levels in patients with autoimmune diseases, such as cutaneous systemic sclerosis, systemic lupus erythematosus and Sjogren's syndrome, compared with normal controls 10, 11.
A common complication in autoimmune connective tissue diseases is vascular involvement 12. A reduction in the number of capillaries has been observed associated with endothelial swelling, basement membrane thickening and hyperplasia of the intima with infiltration of inflammatory cells into the skin 12. Considering this scenario in mind, one can hypothesize that IFI16 is involved in the early steps of inflammation resulting in EC activation -a necessary condition for the development of autoimmune diseases.
The aim of this study was to verify whether inflammatory molecule induction by IFI16 is confined to adhesion molecules, such as ICAM-1, or if it can also be extended to proinflammatory chemokines that are responsible for inflammatory cell recruitment, such as CCL4, CCL5 and CCL20, thereby reinforcing the physiological relevance of IFI16 in the early steps of inflammation.
Results
We have previously analyzed transcriptomes from EC overexpressing IFI16 and found that IFI16 upregulates a complex array of cellular genes encoding inflammatory molecules responsible for leukocyte recruitment 9. Moreover, we showed that IFI16 triggers the expression of EC ICAM-1 9
-an adhesion molecule involved in the enrolment of cells at the site of inflammation during the first steps of inflammation 13. In this study, in order to determine whether IFI16 also induces the secretion of chemokines and cytokines, we first analyzed the IFI16 secretome for 174 common Table 2 . RT-PCR analysis largely confirmed secretome analysis. As shown in Fig. 1 , IFI16 modulates the expression of endothelial genes, such as ICAM-1, implicated in the early steps of inflammation. Indeed, CCL3, CCL4, CCL5, CCL20 and IL-1β were significantly upregulated (33.5-fold, 21-fold, 9.5-fold, 18.5fold and 28.5-fold, respectively), indicating that the RT-PCR results were generally consistent with the expression patterns observed in the secretome analysis (Table 1) . Averages7SD are shown for AdVLacZ-and AdVIFI16-infected intensity values. As IFI16 increases the expression of genes encoding inflammatory chemokines, to confirm these inductions at the protein level, representative chemokines were also quantified by ELISA in supernatants from both LacZ and IFI16 HUVEC supernatants 60 h postinfection. As shown in Fig.   2 , the CCL4 protein levels are 28-fold higher in supernatants from IFI16 HUVEC-infected cells compared with those in the supernatants from LacZ-infected cells (86±24 versus 3±4 pg/mL, mean±SEM), the CCL5 protein levels are fourfold higher (273±39 versus 74±32 pg/mL) and the CCL20 protein levels are about threefold higher in supernatants from IFI16 HUVEC-infected cells (312±30 versus 102±8 pg/mL). This analysis provides the first glimpse into the complexity of the IFI16 secretome and confirms its ability to trigger proinflammatory activity in EC. The IFI16 gene is known to be induced by IFN, however, to confirm the role of IFI16 as the mediator of IFN pro-inflammatory activity, we investigated whether the array of inflammatory molecules stimulated in HUVEC by treatment with IFN-β overlapped with that observed in IFI16infected cells. To do so, EC were treated with IFN-β or left untreated. After 24 h, total RNA were extracted, retrotranscribed into cDNA and analyzed by RT-PCR and the arrays of expressed proinflammatory genes compared. As shown in Fig. 3 , treating HUVEC with IFN-β resulted in the upregulation of a series of proinflammatory genes, including ICAM-1, CCL3, CCL4, CCL5, CCL20 and IL-1β (6.35-fold, 10.4-fold, 6.1-fold, 58.7-fold, 26.8-fold and 8.71-fold, respectively) that were also observed to be upregulated in HUVEC overexpressing IFI16. To determine whether the increase in expression of inflammatory molecules was a consequence of stimulating the encoding genes at the transcriptional level, we analyzed the effects of IFI16 on the expression of the transiently transfected luciferase reporter gene driven by the promoters of either CCL20 or ICAM-1. HUVEC were transiently transfected with the indicated plasmids and then infected with either adenovirus containing the IFI16 gene (AdVIFI16) or AdVLacZ, or otherwise left uninfected. Thirty-six hours postinfection, cell extracts were prepared and assayed for luciferase activity. As shown in Fig. 4 , IFI16 overexpression led to an increase in the expression of the luciferase reporter gene driven by either the CCL20 promoter (3.8-fold) or the ICAM-1 promoter Previous results have demonstrated that NF-κB is the main mediator of IFI16-driven ICAM-1 induction responsible for leukocyte adhesion to the endothelium 9. To determine whether the interaction of IFI16 with NF-κB may also be responsible for the induction of other genes within the IFI16 secretome, functional analysis of the CCL20 gene promoter was performed. To do this, transient transfection assays were performed using either one of the two human CCL20 promoterluciferase constructs: pCCL20 c/EBPmut, containing the full-length human CCL20 promoter bearing the mutated c/EBP site; and the pCCL20 NF-κBmut, containing the full-length CCL20 promoter bearing the mutated NF-κB site 14. As shown in Fig. 4 , site-specific mutation of the single NF-κB responsive motif almost completely blocked the ability of IFI16 to trigger luciferase activity. In contrast, mutation of the single C/EBP site only slightly decreased luciferase activity compared with the wild-type CCL20 promoter.
In order to provide definitive evidence supporting the role of NF-κB as the mediator of CCL20 promoter activation by IFI16, HUVEC were transfected with the indicator plasmid 5× NF-κB luc 15, infected thereafter with AdVIFI16 or AdVLacZ and reporter gene activity subsequently measured 24 h later. As shown in Fig. 4 , overexpression of IFI16 significantly increased NF-κB transactivation of the reporter gene although at levels lower than those observed with the endogenous CCL20 promoter. Altogether, these results demonstrate that IFI16 interacts with NF-κB in order to trigger CCL20 promoter activity, in line with the results obtained from the ICAM-1 promoter analysis. However, NF-κB does not appear to be the only transactivator stimulated by IFI16 in order to trigger CCL20 promoter.
The ligand-receptor pair CCL20-CCR6 is believed to be responsible for the chemoattraction of CD34-derived immature DC, Langerhans DC (L-DC), effector/memory T cells and B cells, and it plays a role at skin and mucosal surfaces under homeostatic and inflammatory conditions 16, 17 . If this is the case, it is important to verify a functional link between the ability of IFI16 to trigger CCL4, CCL5 and CCL20 release by HUVEC and DC and B-lymphocyte chemoattraction. Using a transwell migration assay, we demonstrate that both L-DC and B cells migrate to a significantly greater degree in response to the supernatants from IFI16-infected HUVEC compared with the supernatants from LacZ-infected HUVEC (Fig. 5 ). This migration was significantly reduced by preincubation with the anti-CCL4, anti-CCL5 and anti-CCL20 mAb, but only when added to the supernatants from IFI16-infected HUVEC. In contrast, addition of an unrelated mAb of the same isotype, used as an internal control, did not influence cell migration (data not shown). These results confirm that the secretion of CCL4, CCL5 and CCL20 by IFI16-infected HUVEC is functional and important for inducing L-DC and B-cell migration into the mucosa and skin where these cells are particularly abundant. Moreover, the only partial anti-CCL4, anti-CCL5 and anti-CCL20 mAbinduced inhibition of cell migration can be explained by the finding that the IFI16 secretome also contains other chemoattractant chemokines ( Table 1) 
Discussion
Chemokines, basic proteins that strongly bind to heparin, can induce leukocyte chemotaxis and activation and are intimately involved in various biological processes, including inflammatory responses, hematopoietic regulation and neoangiogenesis 18-20. The chemokines CCL4, CCL5 and CCL20 have been reported as being capable of attracting memory/activated T cells, whereas immature DC and B cells express CCR6 -its specific CC chemokine receptor 20, 21.
Previous DNA microarray analysis has revealed that IFI16 overexpression in EC triggers the expression of proinflammatory adhesion molecules, and functional analysis of the ICAM-1 promoter by site-specific mutagenesis has demonstrated that NF-κB is the main mediator of IFI16driven gene induction 9. However, definitive prove that IFI16 regulates the proinflammatory activity of EC at the functional level has been missing. In this study, protein array analysis of the IFI16 secretome reveals that IFI16 triggers the expression of both intercellular adhesion molecules and chemokines responsible for leukocyte recruitment in vivo. Consistent with these observations, significant increases in the protein levels of CCL4, CCL5 and CCL20 were identified by ELISA in the supernatants of HUVEC overexpressing IFI16. Moreover, studying CCL20 as a representative chemokine, we demonstrate that NF-κB is the relevant mediator of CCL20 gene transcriptional activation following IFI16 overexpression. The relevance of this interaction is highlighted by the finding that the supernatants of IFI16-overexpressing HUVEC trigger the migration of both CCR6positive L-DC and B cells and that this migration is significantly downregulated by the addition of Ab that neutralize CCL4, CCL5 and CCL20.
Inflammation is a complex defence mechanism, which aims to contain and resolve harmful 
Materials and methods

Cell lines and reagents
HUVEC cultured in endothelial growth medium (EGM-2, Lonza, Milan) containing 2% fetal bovine serum, human recombinant vascular endothelial growth factor, basic fibroblast growth factor, human epidermal growth factor, IGF-1, hydrocortisone, ascorbic acid, heparin, gentamycin and amphotericin B (1 µg/mL each) were seeded into 60 mm culture dishes coated with 0.2% gelatin. Experiments were performed with cells between passages 2 and 6. Human embryo kidney 293 cells (Microbix Biosystems) were cultured in minimum Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum (Sigma, Milan, Italy), 2 mM glutamine, 100 units of penicillin per milliliter and 100 µg/mL of streptomycin sulfate.
Recombinant adenovirus preparations and HUVEC infection
Adenovirus-derived vectors expressing either IFI16 or LacZ were generated as described previously 9. Briefly, the pAC-CMV IFI16 containing the human IFI16 cDNA linked to a FLAG tag at the Nterminus was cotransfected together with pJM17 into human embryonic kidney 293 cells. After several rounds of plaque purification, the AdVIFI16 was amplified on 293 cell monolayers and LacZ-and IFI16-infected samples were compared for significance using Student's t-tests. p-Values of <0.05 were considered statistically significant.
Detection of proteins
CCL4, CCL5 and CCL20 chemokines were quantified in LacZ-and IFI16-infected HUVEC supernatants by ELISA (R&D Systems, by SPACE, Milan, Italy) in accordance with the manufacturer's instructions.
Generation of monocyte-derived L-DC and purification of B cells
Human PBMC were isolated from venous blood of voluntary healthy donors using HistoPaque A total of 600 µL of supernatant from LacZ and IFI16 infected HUVEC preincubated or not in the presence of anti-CCL4, anti-CCL5 and anti-CCL20 mAb for 30 min at room temperature were added to the lower chamber. A total of either 1.5×105 L-DC or B cells in 100 µL were added to the upper chamber and incubated at 37°C for 2 h. Cells that migrated into the lower chamber were harvested and counted by flow cytometry acquiring events for a fixed time of 30 s. The range of the control titration curves obtained by testing increasing concentrations of cells. The results are expressed as the mean number of migrated cells±SEM 28. Unpaired Student's t-tests were used to determine whether the differences in migration were statistically significant.
Statistical analyses
Statistical analyses were performed using GraphPad Prism version 5.00 for Windows (GraphPad Software, San Diego, CA, USA, www.graphpad.com).
